A detailed history of Resources Investment Advisors, Llc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 35,831 shares of NVO stock, worth $3.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
35,831
Previous 37,500 4.45%
Holding current value
$3.03 Million
Previous $5.35 Million 20.29%
% of portfolio
0.05%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$119.07 - $145.42 $198,727 - $242,705
-1,669 Reduced 4.45%
35,831 $4.27 Million
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $2.48 Million - $2.97 Million
20,232 Added 117.16%
37,500 $5.35 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $151,122 - $201,161
-1,480 Reduced 7.89%
17,268 $2.22 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $448,906 - $539,271
5,114 Added 37.51%
18,748 $1.94 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $619,756 - $1.36 Million
6,815 Added 99.94%
13,634 $1.24 Million
Q2 2023

Aug 07, 2023

BUY
$155.98 - $172.65 $372,324 - $412,115
2,387 Added 53.86%
6,819 $1.1 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $586,530 - $705,308
4,432 New
4,432 $705,000
Q2 2019

Aug 12, 2019

SELL
$46.79 - $52.47 $13,007 - $14,586
-278 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$46.76 - $51.24 $6,873 - $7,532
-147 Reduced 34.59%
278 $13,000
Q2 2018

Aug 15, 2018

SELL
$44.29 - $50.42 $104,878 - $119,394
-2,368 Reduced 84.78%
425 $20,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $2.1 Million - $2.52 Million
-43,334 Reduced 93.94%
2,793 $138,000
Q4 2017

Jan 31, 2018

BUY
$47.53 - $53.73 $27,234 - $30,787
573 Added 1.26%
46,127 $2.48 Million
Q3 2017

Nov 13, 2017

SELL
$41.15 - $49.22 $22,714 - $27,169
-552 Reduced 1.2%
45,554 $2.19 Million
Q2 2017

Aug 14, 2017

BUY
N/A
46,106
46,106 $1.98 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.